• Merck KGaA appointed Miguel Fernández Alcalde as head of global commercial strategy, replacing retiree Andrew Paterson.
• Fernández Alcalde previously led EMD Serono as North America president; earlier roles included COO, global business excellence head, Finland and Spain general manager.
• Monia Vial named president of EMD Serono, head of North America, succeeding Fernández Alcalde.
• Vial joins from Ipsen Biopharmaceuticals, where she was SVP and head of the U.S. rare disease business unit.
• Both executives will be based in Boston, serving on the healthcare executive committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck KGaA published the original content used to generate this news brief on June 24, 2026, and is solely responsible for the information contained therein.